Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects

[1] Racine M(2014)The Canadian STOP-PAIN project: the burden of chronic pain—does sex really matter? Clin J Pain 30 443-452

[2] Dion D(2013)Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2163-2196

[3] Dupuis G(2012)American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee Arthritis Care Res 64 465-474

[4] Guerriere DN(2010)OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009 Osteoarthr Cartil 18 476-499

[5] Zagorski B(2014)Trends in the use of aspirin and non-steroidal anti-inflammatory drugs in the general US population Pharmacoepidemiol Drug Saf 23 43-50

[6] Choinière M(2005)Prevalence and correlates of osteoarthritis in Germany. Representative data from the First National Health Survey Orthopade 34 782-790

[7] Vos T(2010)Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004–2008—a retrospective patient record review J Pain Res 3 131-135

[8] Flaxman AD(2012)A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity Rheumatol Int 32 1491-1502

[9] Naghavi M(2008)Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents Am J Gastroenterol 103 2908-2918

[10] Lozano R(2009)Guidelines for prevention of NSAID-related ulcer complications Am J Gastroenterol 104 728-738

[1] Racine M(2014)The Canadian STOP-PAIN project: the burden of chronic pain—does sex really matter? Clin J Pain 30 443-452

[2] Dion D(2013)Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2163-2196

[3] Dupuis G(2012)American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee Arthritis Care Res 64 465-474

[4] Guerriere DN(2010)OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009 Osteoarthr Cartil 18 476-499

[5] Zagorski B(2014)Trends in the use of aspirin and non-steroidal anti-inflammatory drugs in the general US population Pharmacoepidemiol Drug Saf 23 43-50

[6] Choinière M(2005)Prevalence and correlates of osteoarthritis in Germany. Representative data from the First National Health Survey Orthopade 34 782-790

[7] Vos T(2010)Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004–2008—a retrospective patient record review J Pain Res 3 131-135

[8] Flaxman AD(2012)A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity Rheumatol Int 32 1491-1502

[9] Naghavi M(2008)Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents Am J Gastroenterol 103 2908-2918

[10] Lozano R(2009)Guidelines for prevention of NSAID-related ulcer complications Am J Gastroenterol 104 728-738